跳至主要内容
临床试验/ACTRN12614000449639
ACTRN12614000449639招募中未知

The significance of hyperglycaemia in survivors of critical illness and potential mechanisms underlying development of type 2 diabetes

Dr Adam Deane0 个研究点目标入组 600 人开始时间: 2014年5月1日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
600

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
30 Years 至 70 Years(—)
性别
All

入选标准

  • Critical Illness-associated hyperglycaemia: HbA1c < 6.5%, blood glucose concentrations > 11.1 mmol/l for at least two consecutive readings during ICU admission
  • Normoglycaemic: HbA1c < 6.5%, fasted blood glucose concentrations remain < 7.1mmol/l and random concentrations remain < 11.1 mmol/l throughout ICU admission
  • Healthy volunteers: >18 years of age, sex and BMI will be used to match volunteers

排除标准

  • Inability to give informed consent, current pregnancy, previous gestational diabetes, acute or chronic pancreatitis, medications known to affect glucose metabolism (e.g. steroids)

研究者

发起方
Dr Adam Deane

相似试验

The significance of hyperglycaemia in survivors of... | 临床试验